Thrombologic news

 
24/02 2012 kl. 15:47
Thrombologic initiates phase IIa trial
Thrombologic initiates it second clinical trial, an exploratory phase IIa in patients with severe community acquired pneumonia. The trial will be run in collaboration with professor Anders Perner of Copenhagen University hospital, it will run in Denmark and Finland. The trials primary end-point is safety and the secondary end-points efficacy. Data is expected to be available 3Q 2013.

 
02/08 2011 kl. 11:18
Thrombologic's first clinical trial meets its primary end-point
 
13/05 2011 kl. 11:29
Recruitment completed for Thrombologic's first clinical trial
 
23/11 2010 kl. 19:26
Thrombologic's 2nd round investment obtained.
 
23/11 2010 kl. 19:23
Patients are recruited.
 
04/08 2010 kl. 15:44
First clinical study expected to start September 2010
 
17/12 2009 kl. 11:13
Biotech start-up Thrombologic launched with seed investment from Novo Seeds and CAT